We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.91B
AUM Growth
-$33.5M
Cap. Flow
-$96.8M
Cap. Flow %
-1.4%
Top 10 Hldgs %
55.6%
Holding
295
New
67
Increased
47
Reduced
98
Closed
74

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$81.6M
2
NVRO
NEVRO CORP.
NVRO
+$68M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$61.4M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$55.5M
5
KDP icon
Keurig Dr Pepper
KDP
+$44.2M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$105M
2
OGN icon
Organon & Co
OGN
+$75.3M
3
EXAS
Exact Sciences
EXAS
+$69M
4
BIIB icon
Biogen
BIIB
+$57.7M
5
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 39.29%
2 Consumer Staples 5.94%
3 Technology 4.58%
4 Consumer Discretionary 4.41%
5 Communication Services 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVF
276
INVO Fertility Inc
IVF
$1.89M
– –
-48
Closed -$882K
CYTH
277
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
– –
-603,000
Closed -$507K
BIG
278
DELISTED
Big Lots, Inc.
BIG
– –
-27,265
Closed -$299K
LL
279
DELISTED
LL Flooring Holdings, Inc.
LL
– –
-13,478
Closed -$51.2K
THMO
280
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
– –
-125,000
Closed -$328K
AVGR
281
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
-31,200
Closed -$384K
ENG
282
DELISTED
ENGlobal Corp
ENG
– –
-277,500
Closed -$1.06M
STAF
283
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
– –
-16,100
Closed -$246K
TRVN
284
DELISTED
Trevena, Inc.
TRVN
– –
-13,141
Closed -$230K
DMK
285
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-207,143
Closed -$1.68M
VMW
286
DELISTED
VMware, Inc
VMW
– –
-68,000
Closed -$8.49M
ACER
287
DELISTED
Acer Therapeutics Inc
ACER
– –
-2,204,694
Closed -$1.67M
FORG
288
DELISTED
ForgeRock, Inc.
FORG
– –
-456,000
Closed -$9.39M
DICE
289
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-1,376,000
Closed -$39.4M
AJRD
290
DELISTED
Aerojet Rocketdyne Holdings
AJRD
– –
-68,000
Closed -$3.82M
NOVN
291
DELISTED
Novan, Inc. Common Stock
NOVN
– –
-2,247,248
Closed -$2.92M
ISEE
292
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,836,000
Closed -$44.7M
PRVB
293
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-400,000
Closed -$9.64M
CUEN
294
DELISTED
Cuentas Inc. Common Stock
CUEN
– –
-121,009
Closed -$662K
SRGA
295
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
– –
-1,309,000
Closed -$2.09M
8 9 10 11
12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Armistice Capital held 295 positions worth $6.91B, down 0.48% from $6.94B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital's Q2 2023 filing shows 67 new, 47 increased, 98 reduced and 74 closed positions. Its largest new stake was Pfizer: 2,096,000 shares worth $76.9M. The largest sale was GSK, an estimated $105M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Consumer Staples and Technology.

  • Armistice Capital's largest Q2 2023 buy was Pfizer: 2,096,000 shares worth $76.9M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2023, an estimated $55.5M increase.
  • Armistice Capital's biggest Q2 2023 reduction was GSK, cutting an estimated $105M.
  • Armistice Capital fully exited Organon & Co in Q2 2023, selling an estimated $75.3M.
  • Armistice Capital's ten largest holdings make up 56% of its $6.91B portfolio in Q2 2023.
  • Armistice Capital opened 67 new positions and closed 74 in Q2 2023.
  • Armistice Capital's portfolio value fell 0.48% quarter-over-quarter to $6.91B.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.